Abbott Pioneers New Liquid Dosing Device, LiDoCon, in India

BANGALORE, November 8, 2017 – Anyone who has taken a liquid medication before knows that it can be messy, sticky and hard to know if you’re getting the right amount. To help solve this challenge, Abbott has pioneered in India LiDoCon, short for Liquid Dosing Concept, a first of its kind device for liquid medicines that provides accurate, hygienic and convenient dosing. This novel technology currently is being used for a cough syrup, but in time, will be extended to different types of liquid formulations. LiDoCon was conceptualized at Abbott’s Innovation and Development Center in Mumbai.

"Our goal is to help people get and stay healthy. If you’re taking medicine to get better, you have to know you’re getting the right amount," said Raviraj Pillai, Head of Abbott’s pharmaceutical Innovation and Development Center in Mumbai. "Our new LiDoCon dosing device is simple, compact and helps avoid spillage and product contamination. This provides safer, more accurate and convenient dosing of liquid medicines, ultimately making it easier for people to take their medicine and get better."

 

The special LiDoCon cap is locked on to the neck of the bottle. By a simple four-step process of "Fill, Invert, Lock and Revert," a specific amount of liquid is dispensed, ensuring that there is no backflow. A premeasured quantity is dispensed from the bottle, which means that no washing is required. This greatly reduces risk of contamination and reduces overall preparation time.

 

The insights behind LiDoCon originally came from an Abbott employee in Mumbai, whose son suffers from asthma. His family experienced the herculean task of constantly cleaning and keeping track of the various dispensing caps from his son’s multiple syrups. That is when he approached Abbott’s innovation team for a solution. LiDoCon was born of a practical need felt by a parent so that monitoring of dosage and hygiene could be made easy.

Physicians across the country have shown a positive response tothis new dosing technique.

 

Dr R. H. Merchant MD Paediatrics, from Bandra in Mumbai says,“LiDoCon technology solves the over dosing problem. It also takes care ofhygiene issues, which is a big problem in India.”

 

Mohammad Athar Ansari, M.D., associate professor of pediatrics atNalanda Medical College and Hospital in Patna said, "LiDoCon is the bestdosing concept I have seen for children. It is safe and hygienic to use, whichis very important, especially from a child’s perspective."

 

The importance of this statement is validated by a study in Pediatrics,the official journal of the American Academy of Pediatrics, published in May2017. The study describes the safety profile and risk factors associated withcough and cold medications from the largest pediatric safety surveillance studyon these products.⁰The study states that medication errors by parents accountedfor 13 percent of exposures to adverse events, while 67.1 percent exposureswere due to accidental unsupervised ingestion by children.

 

LiDoCon ensures that only a measured amount is dispensed, and henceprevents overdosing and accidental ingestion of a large amount of liquid.

 

"At Abbott, we constantly strive to make technology userfriendly, while maintaining safety and efficacy at all times," Ravirajsaid.


  (0)   Comment